Lescarden, Inc. is a publicly-owned biotechnology company focused on the development of natural biologic therapies for the chronic wound care, dermatology and osteoarthritis markets. Lescarden’s research team, led for many years by one of its founders, Dr. John Prudden, is responsible for the breakthrough studies conducted with bovine cartilage. These efforts brought the Lescarden team to the successful development of
Catrix , a product that is recognized for its therapeutically diverse applications, both systemic and topical. These applications include: Chronic wound healing Dermatology/Skin Care Inflammatory joint disease Metastatic renal cell cancer
1 Products shopping cart
Filter Options
